- Total Pro Portfolios with MNT:
- Buffalo Science & Technology BUFTX
- show more
- Total Do-It-Yourself Portfolios with MNT:
- marja Portfolio 1
- Joel Morrell Portfolio 1
- andrysia Portfolio 1
- SUPRATRADE THURSDAY PICK IV
- dbbfmt Portfolio 1
- tvoogel Portfolio 1
- Texason3 Portfolio 1
- hrdwrk30 Portfolio 1
- gilig Portfolio 1
- jabbruzzesi 6-20-07
- osirH 4
- Skin Deep
- SUPRATRADE-2009072039
- woody's portfolio 1
- EME in Real
- Healthcare Short Squeeze Plays
- Cramer's Merger Wave Stocks
- show more
- 34
- pat's picks
- bruce lipskind
- sample1p9[jn
- falling knives
- 77Capital holdings
- monkey Portfolio 1
- EMWs Picks
- Nothing but Winners
- SUPRATRADE1806071535
- jkkwan324 Portfolio 1
- tjjackson Portfolio 1
- SUPRATRADE FOCUS-2408070204
- PANTERA GROUP 199
- PART 9 JPMorgan 26th Annual Healthcare Conf 1/10/08..4th Day Reporting Companies..Nymph Take
- Top Healthcare Short Squeezes
- NYSE Short Squeeze Plays for August
- Barron's Activist Stocks 1-03-2009
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:01 03 09 |
Funds managed by Mario Gabelli's Gamco Investors (GBL) reported ownership of 2,139,500 shares (6.33%) after buying 1,841,500 from Oct. 30 to Dec. 24 at prices ranging from $15.94 to $30.87. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:12 03 08 |
How can Johnson & Johnson (JNJ) be the only company that sees a bargain here? How can only JNJ have enough cash to buy a company, Mentor (MNT), that has been shrunk to a level nobody thought possible? |
|
Not yet rated
Rate now:
|
|
Date:08 12 08 |
|
25.1 |
|
Not yet rated
Rate now:
|
|
Date:07 09 08 |
|
27.2 |
|
Not yet rated
Rate now:
|
|
Date:04 24 08 |
|
13.5 |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Allergan Avoids Market's Browbeating |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Mentor (MNT) was upgraded from Sector Perform to Outperform, CIBC said. Valuation is at an attractive level, and silicone conversion is improving. $48 price target. |
|
Not yet rated
Rate now:
|
|
By:woody_gentry |
Date:11 25 07 |
growing revenues low stock price |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Mentor (MNT) was downgraded from Neutral to Sell, Merrill Lynch said. Valuation call, especially as competition with AGN is heating up. |
|
Not yet rated
Rate now:
|
|
By:supratrade |
Date:08 23 07 |
HOLD |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |








